Fisetin for intermittent claudication

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 May 2024: Trial registered, NCT06399809
  2. 30 Sep 2024: Trial started, NCT06399809

The trials

NCT06399809: Fisetin to Reduce Senescence and Mobility Impairment in PAD

State
Under way
Phase
Phase 2
People
34 planned
Started
30 Sep 2024
Primary completion
30 Jun 2027
Arms
Fisetin
Results
None posted
  1. 6 May 2024: Trial registered
  2. 30 Sep 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.